Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid plus oxytocin for bleeding reduction during emergency caesarean section
PACTR202605886170737Not yet recruiting
- Sponsor
- Seif
- Start
- May 2026
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tranexamic acid and oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Seif. Primary endpoint: Mean intraoperative blood loss. Planned start May 2026; status: not yet recruiting.
02
Drugs
tranexamic acidoxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202605886170737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202605886170737.